Eurosurveillance annual theme 2025: Eurosurveillance opens submissions on vaccine-preventable diseases in humans — today's challenges and tomorrow's opportunities

References

1. World Health Organization (WHO). Vaccines and immunization. Geneva: WHO; 2024. Available from: https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1
2. Ford A, Hwang A, Mo AX, Baqar S, Touchette N, Deal C, et al. Meeting summary: global vaccine and immunization research forum, 2021. Vaccine. 2023;41(11):1799-807.  https://doi.org/10.1016/j.vaccine.2023.02.028  PMID: 36803897 
3. European Centre for Disease Prevention and Control (ECDC). Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries. Stockholm: ECDC; 30 Nov 2023. Available from: https://www.ecdc.europa.eu/en/publications-data/interim-analysis-covid-19-vaccine-effectiveness-against-hospitalisation-and-death
4. Martínez-Baz I, Miqueleiz A, Casado I, Navascués A, Trobajo-Sanmartín C, Burgui C, et al. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021. Euro Surveill. 2021;26(21):2100438.  https://doi.org/10.2807/1560-7917.ES.2021.26.21.2100438  PMID: 34047271 
5. World Health Organization (WHO). Smallpox and mpox (orthopoxviruses): WHO position paper, August 2024. Geneva: WHO; 23 Aug 2024. Available from: https://www.who.int/publications/i/item/who-wer-9934-429-456
6. Wolff Sagy Y, Zucker R, Hammerman A, Markovits H, Arieh NG, Abu Ahmad W, et al. Real-world effectiveness of a single dose of mpox vaccine in males. Nat Med. 2023;29(3):748-52.  https://doi.org/10.1038/s41591-023-02229-3  PMID: 36720271 
7. Bertran M, Andrews N, Davison C, Dugbazah B, Boateng J, Lunt R, et al. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. Lancet Infect Dis. 2023;23(7):828-35.  https://doi.org/10.1016/S1473-3099(23)00057-9  PMID: 36924787 
8. World Health Organization (WHO). Guidelines on the quality, safety and efficacy of respiratory syncytial virus vaccines, Annex 2, TRS No 1024. Geneva: WHO; 11 Nov 2020. Available from: https://www.who.int/publications/m/item/respiratory-syncytial-virus-vaccines-annex-2-trs-no-1024
9. European Commission (EC). European vaccination information portal. RSV. Brussels: EC. [Accessed: 25 Sep 2024]. Available from: https://vaccination-info.europa.eu/en/rsv
10. Rupprecht CE, Buchanan T, Cliquet F, King R, Müller T, Yakobson B, et al. A global perspective on oral vaccination of wildlife against rabies. J Wildl Dis. 2024;60(2):241-84.  https://doi.org/10.7589/JWD-D-23-00078  PMID: 38381612 
11. World Health Organization (WHO). Rabies vaccines: WHO position paper – April 2018. Geneva: WHO; 2018. Available from: https://www.who.int/publications/i/item/who-wer9316
12. Food and Agriculture Organization (FAO). Towards zero human deaths from dog-mediated rabies by 2030. Rome: FAO; 2024. Available from: https://openknowledge.fao.org/items/2b2dd878-4de5-45d3-b0ad-de6e4e01880a
13. Frank MG, Weaver G, Raabe V, State of the Clinical Science Working Group of the National Emerging Pathogens Training, Education Center’s Special Pathogens Research Network2, State of the Clinical Science Working Group of the National Emerging Pathogens Training, Education Center’s Special Pathogens Research Network. Crimean-Congo hemorrhagic fever virus for clinicians – diagnosis, clinical management, and therapeutics. Emerg Infect Dis. 2024;30(5):864-73.  https://doi.org/10.3201/eid3005.231648  PMID: 38666553 
14. Blasco JM, Moreno E, Muñoz PM, Conde-Álvarez R, Moriyón I. A review of three decades of use of the cattle brucellosis rough vaccine Brucella abortus RB51: myths and facts. BMC Vet Res. 2023;19(1):211.  https://doi.org/10.1186/s12917-023-03773-3  PMID: 37853407 
15. Rossetti CA, Maurizio E, Rossi UA. Comparative review of brucellosis in small domestic ruminants. Front Vet Sci. 2022;9:887671.  https://doi.org/10.3389/fvets.2022.887671  PMID: 35647101 
16. Hogerwerf L, van den Brom R, Roest HIJ, Bouma A, Vellema P, Pieterse M, et al. Reduction of Coxiella burnetii prevalence by vaccination of goats and sheep, The Netherlands. Emerg Infect Dis. 2011;17(3):379-86.  https://doi.org/10.3201/eid1703.101157  PMID: 21392427 
17. Zendoia II, Barandika JF, Cevidanes A, Hurtado A, García-Pérez AL. Coxiella burnetii infection persistence in a goat herd during seven kidding seasons after an outbreak of abortions: the effect of vaccination. Appl Environ Microbiol. 2024;90(3):e0220123.  https://doi.org/10.1128/aem.02201-23  PMID: 38412030